Skip to main content
. 2009 Dec 29;46(1):73–80. doi: 10.3164/jcbn.09-56

Table 4.

Incidences of risk factors for anticholinergic agents and glucagon in patients undergoing gastrointestinal endoscopy

Risk (n = 1480)
No risk 49.9% (738)
Anticholinergic 41.6% (616)
Glucagon 3.8%* (56)
Anticholinergic & Glucagon 4.7%** (70)

All data were expressed as mean. Analyses were conducted using Fisher’s exact method (chi-square test).

*Anticholinergic Group vs Glucagon group (p<0.001)

**Anticholinergic Group vs Anticholinergic & Glucagon group (p<0.001)